• BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
FinanceTime
  • August 20th, 2026

FinanceTimeFinancetime

  • BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
E. Jean Carroll exits Manhattan Federal Court, in the second civil trial after she accused former U.S. President Donald Trump of raping her decades ago, in New York City, U.S., January 18, 2024. Eduardo Munoz
E. Jean Carroll exits Manhattan Federal Court, in the second civil trial after she accused former U.S. President Donald Trump of raping her decades ago, in New York City, U.S., January 18, 2024. Eduardo Munoz
Home
Litigation

Trump defamation trial delayed by COVID concerns; he could testify on Wednesday

January 22nd, 2024 | 16:21 PM Litigation 3

Facebook Twitter Google+ LinkedIn Pinterest

Worth reading...

Novonesis expects results from weight-loss drug supplement study in 2027
Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump
Ping An Insurance's first-half profit jumps 36% on asset management boost
Australia passes law to levy tech giants that fail to pay for local news
By Jonathan Stempel, Luc Cohen

Donald Trumpmay be set to testify in the writer E. Jean Carroll's latest civil defamation trial in Manhattan federal court on Wednesday, following a two-day postponement triggered by COVID-19 concerns.

U.S. District Judge Lewis Kaplan canceled testimony on Monday after one juror who felt ill was sent home for a COVID test, and Trump's lawyer Alina Habba said she caught a fever after dining with her parents, one of whom contracted the virus.

Tuesday's trial session was later also canceled, a court officer said.

The trial concerns Trump's June 2019 denials of Carroll's claim that he raped the former Elle magazine advice columnist in the mid-1990s in a Bergdorf Goodman department store dressing room in Manhattan.

A different jury last May ordered Trump to pay Carroll $5 million over a similar October 2022 denial.

Kaplan has ruled that the first trial established that Trump defamed and sexually abused Carroll.

The only issue for the nine jurors in the second trial is how much money Trump should pay Carroll, if any. Carroll, 80, is seeking at least $10 million.

Prior to the postponement, Habba said Trump "had been planning to testify" after Carroll's lawyers finished presenting their case.

Trump plans to be in New Hampshire on Tuesday for that state's Republican presidential primary, where he has been leading in opinion polls.

The winner of the nomination is expected to face President Joe Biden, the likely Democratic nominee, in November.

Carroll's lawyer Roberta Kaplan, who is not related to the judge, said she had a "very short" amount of testimony left to present.

Habba and her co-counsel, Michael Madaio, tested negative for COVID-19 on Monday. Neither they nor Trump wore masks in the courtroom.

NO MISTRIAL

Trump, 77, has consistently denied wrongdoing, and accused Carroll of making up their encounter to boost sales of her then-new memoir.

In a post on his Truth Social website following Monday's postponement, Trump maintained that he knows "absolutely nothing about" Carroll, and that the case was "one of the many Crooked Joe Biden-inspired Witch Hunt trials."

Trump has also pleaded not guilty in four criminal cases, including two claiming he tried illegally to overturn his 2020 loss to Biden.

Judge Kaplan separately denied Trump's request for a mistrial, which arose from Carroll testifying that she destroyed emailed death threats after first accusing Trump of rape.

Trump did not attend Carroll's first trial, and attended jury selection and the first full day of her second trial.

He is not required to testify, and Carroll's lawyers have argued he might try to "sow chaos" if he did, perhaps believing that doing so would help him politically.

Last Wednesday, Judge Kaplan warned Trump he might be ejected for being disruptive in the courtroom, after a lawyer for Carroll said jurors might have overheard Trump loudly proclaim the trial a witch hunt and "con job."

"I would love it," Trump said.

"I know you would," Kaplan replied.

  • Topic
  • USA
  • TRUMP/DEFAMATION
  • LAWSUIT (UPDATE 6, PIX, TV)
Facebook Twitter Google+ LinkedIn Pinterest
Previous article Novonesis expects results from weight-loss drug supplement study in 2027

Related Posts

Litigation
August 20th, 2026

Novonesis expects results from weight-loss drug supplement study in 2027

Litigation
August 20th, 2026

Celon Pharma's generic semaglutide drug matches Ozempic in early study, ...

Litigation
August 20th, 2026

Ping An Insurance's first-half profit jumps 36% on asset management boos...

Litigation
August 20th, 2026

Australia passes law to levy tech giants that fail to pay for local news

Litigation
August 20th, 2026

SK Hynix to pay 60% of employee bonuses in company stock under prelimina...

Litigation
August 20th, 2026

CK Hutchison seeks $1.5 billion from Panama in treaty dispute arbitratio...

The Wire
Aug 20th 4 h ago
Business

AI productivity gains may not curb inflation, IMF's Tenreyr...

Aug 20th 4 h ago
Aerospace & Defense

Latvia says drone in its airspace on August 14 was Ukrainia...

Aug 20th 4 h ago
India

Indian central bank deputy urges banks to improve retail fo...

Aug 20th 4 h ago
Baseball

Guardians chase elusive home series win in matchup vs. Gian...

Aug 20th 4 h ago
Americas

Brazil to keep fiscal framework, spending restraint under n...

TRENDING ON FINANCETIME
Aug 20th, 2026 Asia Pacific

Bangladesh elects ruling party veteran Alamgir as president

Aug 20th, 2026 Africa

AFRICA-FX-Ghana's currency back under pressure, Uganda's on front foot

Aug 20th, 2026 Soccer

How would a vote of no confidence work to oust FIFA president Infantino?

Aug 20th, 2026 Europe

Romania destroys marine drone near Neptun Deep gas project, minister says

Aug 20th, 2026 Baseball

Sal Stewart, Reds strive for edge in finale of 5-game series vs. Cards

Markets-Sectors
TELECOMMUNICATIONS SERVICES +0.03%

  • BUSINESS
  • MARKETS
  • WORLD
  • POLITICS
  • TECH
  • COMMENTARY
  • BREAKINGVIEWS
  • MONEY
  • LIFE
  • SECTORS
  • Back to top
FinanceTime
FinanceTime

World Business & Financial News, Breaking US & International News

Additional Services
  • Privacy-Policy
  • Terms and Conditions
© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT